CONFERENCE COVERAGE
Alzheimer's Association International Conference
Annual Meeting
2018 COVERAGE
- Promising Improvements in Mild Cognitive Impairment With Investigational NA-831
- Tramiprosate Associated With High Response, Favorable Safety in APOE ε4 Homozygotes With Mild Alzheimer's
- Twice-Daily Oxaloacetate Activates Brain Bioenergetic Metabolism in Alzheimer Disease
- Citicoline Plus Memantine Superior to Memantine Alone for Improving Cognition in Alzheimer’s Dementia
- New Monoclonal Antibody BAN2401 Reduces Amyloid Plaques, Improves Cognition in Alzheimer's
- Investigating the Effects of Z-Drugs in Dementia Patients With Sleep Disturbances
- Metformin Associated With Increased Dementia Risk in African Americans With Diabetes
- Pimavanserin Confers Greater Improvements in Alzheimer Disease Psychosis vs Placebo
- Transdermal Buprenorphine Not Well Tolerated in Dementia
- Cannabinoid Shows Promise for Reducing Agitation, Aggression in Alzheimer Disease
- Sugary Drinks, Other Added Sugars May Up Risk for Alzheimer Disease
- Intensive Blood Pressure Control Cuts Combined Mild Cognitive Impairment, Dementia Risk
Latest Tweets
Follow
@NeuroAdvisor
Conference Coverage from
